Actively Recruiting
Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy
Led by Tanta University · Updated on 2025-03-26
46
Participants Needed
1
Research Sites
49 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of current study is to: Evaluate the cardioprotective effects of melatonin in patients with cardiomyopathy.
CONDITIONS
Official Title
Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (≥18 years) with a confirmed diagnosis of cardiomyopathy based on clinical, echocardiographic, or imaging findings.
- Stable condition on standard cardiomyopathy medications (e.g., ACE inhibitors, beta-blockers).
- Ability to provide informed consent.
You will not qualify if you...
- Recent hospitalization for cardiomyopathy exacerbation within the last 3 months.
- Severe kidney or liver impairment.
- Use of other investigational drugs or antioxidants.
- Pregnancy or planning to be pregnant in the next 6 months.
- Previous known hypersensitivity to melatonin.
- Presence of atrial fibrillation or other significant arrhythmias at baseline.
- Participation in another research study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mansoura University Hospital
Dakahlia, Egypt, Mansoura, Egypt, 35516
Actively Recruiting
Research Team
R
Reem Alaa, Bachelor of Pharmacy (2023)
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here